Deep Mutational Scanning to Predict Escape from Bebtelovimab in SARS-CoV-2 Omicron Subvariants
暂无分享,去创建一个
[1] C. Wong. Subvariant ‘soup’ may drive wave , 2022, New Scientist.
[2] J. Zahradník,et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant , 2022, Cell Host & Microbe.
[3] A. Walls,et al. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains , 2022, bioRxiv.
[4] Fei Shao,et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection , 2022, Nature.
[5] Jumpei Ito,et al. Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies , 2022, The Lancet Infectious Diseases.
[6] K. Katoh,et al. An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo , 2022, Science Translational Medicine.
[7] J. Dye,et al. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants , 2022, Cell Reports.
[8] Shinji Watanabe,et al. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 , 2022, The New England journal of medicine.
[9] D. Fremont,et al. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies , 2022, Nature Medicine.
[10] P. Maes,et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization , 2021, Nature.
[11] P. Pang,et al. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. , 2021, The New England journal of medicine.
[12] J. Takagi,et al. Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 , 2021, Nature Communications.
[13] L. Purcell,et al. Tackling COVID-19 with neutralizing monoclonal antibodies , 2021, Cell.
[14] E. Procko,et al. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants , 2021, Science Advances.
[15] J. Bloom,et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 , 2021, Science.
[16] D. Skovronsky,et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 , 2020, The New England journal of medicine.
[17] G. Atwal,et al. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters , 2020, Science.
[18] Sarah K. Hilton,et al. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding , 2020, Cell.
[19] Caitlyn E. Bowman,et al. The ATP/ADP translocase drives mitophagy independent of nucleotide exchange , 2019, Nature.
[20] Trevor Bedford,et al. Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants , 2018, Proceedings of the National Academy of Sciences.
[21] Sarah K. Hilton,et al. Mapping mutational effects along the evolutionary landscape of HIV envelope , 2017, bioRxiv.
[22] H. Schwalbe,et al. Retroviral Vectors Pseudotyped with Severe Acute Respiratory Syndrome Coronavirus S Protein , 2004, Journal of Virology.